Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.
about
HIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsA role for human brain pericytes in neuroinflammation.Unperturbed posttranscriptional regulatory Rev protein function and HIV-1 replication in astrocytesEndocytosis-mediated HIV-1 entry and its significance in the elusive behavior of the virus in astrocytes.CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.Homeostatic interferon expression in neurons is sufficient for early control of viral infectionCerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND)Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsTarget of HIV-1 Envelope Glycoprotein gp120-Induced Hippocampal Neuron Damage: Role of Voltage-Gated K(+) Channel Kv2.1.HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest?HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.HIV/neuroAIDS biomarkers.Glial biomarkers in human central nervous system disease.Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection.HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients.Palm Fruit Bioactives modulate human astrocyte activity in vitro altering the cytokine secretome reducing levels of TNFα, RANTES and IP-10
P2860
Q28392199-7DEAAD75-47D1-4F35-A106-C186653CA2BDQ33926836-9C486E79-0507-4F47-9092-4D29D3538A04Q34134540-5D0CAA68-66C6-43DE-A9FF-3140E105E506Q34264416-A68606BF-C197-453A-9754-AD84905E097DQ35023230-4873EB71-45D1-4731-9475-7FCF9C5463B5Q35075450-67DAC6AD-D065-4FCB-912D-169844E5E406Q35125862-48F79D13-A381-41DE-8B1D-9679CB85DF25Q35125996-B646E62A-2565-4C1D-A9CE-D65A69EB4D4DQ36131249-826DE6C8-7115-4D9E-8100-752D01AF60BFQ36238501-779FEF68-FA66-4C43-8176-5BDD30B58C6FQ36274448-6C6B54E6-A1DD-4798-8FE1-3B06F2FAA505Q38248964-C2C943C7-F82D-4D36-85A1-5CFE5617A21EQ38725384-AF0D4A14-D31F-42FC-BE0C-D2CC83806393Q38809646-8E1787F0-02E4-4251-9E59-09B716460A3AQ38845041-0E82361C-C10C-4F18-9AC5-60B07A3904F5Q40472266-4EF80F31-99B7-4D67-A654-D5B525F65264Q47342684-C38CEA39-74D4-4C3A-B8B5-EE181EDDFEC6Q58608796-3FB7FBBA-3256-4665-938A-74513D1BC8BA
P2860
Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@ast
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@en
type
label
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@ast
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@en
prefLabel
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@ast
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@en
P2093
P2860
P356
P1476
Programming of neurotoxic cofa ...... ity in vitro by PKC activator.
@en
P2093
Ashok Chauhan
Mitzi Nagarkatti
Rajeev Mehla
Shalmali Bivalkar-Mehla
P2860
P2888
P356
10.1186/1742-2094-9-239
P577
2012-10-18T00:00:00Z
P5875
P6179
1018417303